Polycythemia Emmanuel Akuna 1412. Lab values. Normal platelet 150,000 - 300,000 CELLS/MM 3 Hemoglobin- men-13.6-17.2 g/dl women-12.0-15.0 g/dl Hematocrit.

Slides:



Advertisements
Similar presentations
Neel Bhalala (2009) Sofia Medical University. Background  Erythropoiesis-stimulating agents are man-made versions of a natural protein known as erythropoietin.
Advertisements

Alterations of Erythrocyte Function
Lecture – 3 Dr. Zahoor Ali Shaikh
MLAB Hematology Keri Brophy-Martinez
NEOPLASTIC DISORDERS OF THE BONE MARROW
Myeloproliferative Disorders (Neoplasm)II Dr. Ibrahim. A. Adam.
Polycythemia Vera (lots of red cells - for real)
Chapter 5 Diagnostic Testing. Overview of Diagnostic Testing PURPOSE OF DIAGNOSTIC TESTING  To help determine the exact cause of signs or symptoms 
WHO CLASSIFICATION OF MYELOID NEOPLASMS 2000  Chronic myeloproliferative disorders (CMPD)  Myelodysplastic / myeloproliferative diseases (MDS/MPD) 
APMG Pathologist, MD FCAP
Morning Report 7/7/2010 Pahresah Roomiany.  Factor V Leiden  Prothrombin gene mutation  Protein C/S deficiency  Antithrombin deficiency  Malignancy.
Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital
Polycythemia Victor Politi, M.D., FACP Medical Director, SVCMC, School of Allied Health Professions, Physician Assistant Program.
Chapter 7 Disorders of Blood Cells Lecture 7 The Nature of Disease Pathology for the Health Professions Thomas H. McConnell.
Myeloproliferative Neoplasms 2015
MLAB Hematology Keri Brophy-Martinez
Differential Diagnosis
MLAB Hematology Keri Brophy-Martinez Unit 23: CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
GRACE ORDUNG Polycythemia. What is Polycythemia? Abnormal increase in blood cells  Red, white and platelets Classified as a cancer Acquired not heredity.
Ahmad Sh. Silmi Msc Haematology, FIBMS.  The Non-leukaemic Malignant Disorders are originally defined, as an amorphous group of malignant disorders which.
Lecture 2 Red Blood Cells, Anemias & Polycythemias
THROMBOTIC COMPLICATIONS IN PATIENTS WITH POLYCYTHEMIA VERA Coordinator: Asist. Univ. Dr. Marcela Candea Authors: Ioana-Violeta Oltean Ioana Barsan Madalina.
Myeloproliferative disorders Dr. Tariq Roshan PPSP Department of Hematology.
Myeloproliferative Disorders (MPD) concepts Neoplastic (clonal) disorders of hemopoietic stem cells Over-production of all cell lines, with usually one.
The Chronic Myeloproliferative Disorders (MPD) A JENABIAN MD.
Myeloproliferative disorders Clonal haematopoeitic disorders Proliferation of one of myeloid lineages –Granulocytic –Erythroid –Megakaryocytic Relatively.
Myeloproliferative Disorders (MPDs)
Cancer of the blood: Leukemia
Red blood Cell Changes and Circulatory problems
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Hypercoagulable States: Polycythemia Vera Chris Caulfield AM Report Oct 20, 2009.
ERYTHROCYTE II (Anemia Polycythemia)
Chicago Medical School
Definition of polycythemia
Myeloproliferative Diseases Mark D. Browning, M.D. Oncology/Hematology Associates February 24, 2016.
Myeloprolifrative disorders Dr.musa Qasim Hussein Assistant professor Consultant physician 29th feb.2016.
Physiology of Red Blood Cells (RBCs) Erythrocytes
Blood Testing. Learning Objective  To identify the types of tests performed on blood  To explain why these tests are useful  To discover the normal.
Gary Schiller, MD Nothing to disclose Discussion of off-label drug use: not applicable 56 th ASH Annual Meeting Disclosure Statement.
AN APPROACH TO THE ANEMIC PATIENT. Prevalence and causes of anemia world-wide Blood 2014;123:615 Us More common in women Iron deficiency most common cause.
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Myeloprolifrative disorders
Definition of polycythemia
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
Myelodysplastic Syndromes Myeloproliferative Disorders
Pediatric polycytemia case presentation
MYELOPROLIFERATIVE DISEASES
Sickle Cell anemia  .
Definition of polycythemia
MYELOPROLIFERATIVE DISORDERS
Polycythemia Vera Bleeding Disorders
POLYCYTHEMIA VERA.
RBC disorders 5 Ahmad Mansour, MD.
Packed cell volume (PCV) or Haematocrit (HCT)
CHRONIC MYELOID LEUKEMIA (CML)
Do you have any suggestions? Please contact us!
Patient A.
Red Blood Cell Disorders
Case Study ….
Chronic Leukemia Kristine Krafts, M.D..
Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms
Practical Clin Path Polycythemia
Erythropoietin (EPO) Mike Lin.
Male patient of 52 years old with a two-year history of fatigue and pruritus of his legs , headache . And visual disturbances . He smoked one pack of.
Polycytemia Dr. Mamlook Elmagraby.
Neoplastic disorder.
Chronic Leukemia Dr. Noha Noufal.
The Non – Leukemic Myeloproliferative Disorders
Presentation transcript:

Polycythemia Emmanuel Akuna 1412

Lab values. Normal platelet 150, ,000 CELLS/MM 3 Hemoglobin- men g/dl women g/dl Hematocrit (HCT) Men % women % Red cell count ×10 6 /mm 3 Men Women Normal Total WBC count == 4500 – /cubic millimetre

Polycythemia, or erythrocytosis denotes an increase in red cells per unit volume of peripheral blood usually in association with an increase in hemoglobin concentration

Polycythemia may be: absolute (defined as an increase in total red cell mass) relative.

Absolute polycythemia described as: Primary: when the increased red cell mass results from an autono-mous proliferation of erythroid progenitors (polycythemia vera) Secondary: when the excessive proliferation stems from elevated levels of erythropoietin.

Polycythemia Vera (primary) Neoplastic proliferation of mature myeloid cells, especially RBC. Granulocyte and platelets are also increased. Associated with JAK2 mutation, A tyrosine kinase Valine to phenylalanine substitution at residue 617 Decreased EPO.

Morphology The major anatomic changes in polycythemia vera stem from increases in blood volume and viscosity liver is enlarged spleen usually is slightly enlarged (250 to 300 g) thromboses and infarctions( Due to increased viscosity and stasis)

Morphology Hemorrhages due to excessive distention of blood vessels and abnormal platelet function. (gastrointestinal tract, oropharynx, or brain are most affected.) Dysfunctional platlets Peripheral blood often shows basophilia. bone marrow is hypercellular In a subset of patients, this progresses to a spent phase where the marrow is largely replaced by fibroblasts and collagen.

Clinical symptoms Blurry vision, headache, dizziness, hematemesis, Increased risk of venous thrombosis that may give rise to Budd-Chiari syndrome Flushed face due to congestion Pruritus and gastric ulcer. Gout (5%-10%) or Asymptomatic hyperuricemia

Diagnosis Made in the lab RBC counts range from 6 to 10 million/µl hematocrit is often 60% or greater granulocyte count can be as high as 50,000 cells/L platelet count is often over 400,000/L (functionally abnormal) Basophilia is common

Treatment Phlebotomy. In those receiving no treatment, death occurs from vascular complications within months. With treatment median survival is increased to about 10 years by lowering the red cell count.

Secondary Polycythemia Increased erythropoietin levels Adaptive: lung disease, high-altitude living, cyanotic heart disease Paraneoplastic: erythropoietin-secreting tumors (e.g., renal cell carcinoma, cerebellar hemangioblastoma, hepatocellular carcinoma)

Relative polycythemia (hemoconcentration) Results from dehydration, such as occurs with water deprivation prolonged vomiting Diarrhea excessive use of diuretics

USLME CONCEPT In PV SaO2 is normal and EPO is decreased. Secoundary polycythemia due to lung disease SaO2is decreased and EPO is increased. In secoundary polycythemia due to ectopic EPO. Sao2 is normal and EPO is increased.

QUESTION?

References Robbins review of pathology Pathoma video First aid (highest yield)

THANK YOU!!!